Book contents
- Atlas of Pediatric Hematopathology
- Atlas of Pediatric Hematopathology
- Copyright page
- Contents
- Contributors
- Section I Peripheral Blood
- Section II Normal and Non-neoplastic Hematolymphoid Diseases
- Section III Mature Lymphoid Neoplasm
- Section IV Precursor Hematopoietic Neoplasms and Related Neoplasms
- Chapter 13 Precursor Lymphoblastic Leukemia/Lymphoma
- Chapter 14 Blastic Plasmacytoid Dendritic Cell Neoplasm
- Chapter 15 Acute Myeloid Leukemia and Related Precursor Neoplasms
- Chapter 16 Myeloproliferative Neoplasms
- Chapter 17 Myelodysplastic/Myeloproliferative Neoplasms
- Chapter 18 Childhood Myelodysplastic Syndrome
- Chapter 19 Germline Predisposition to Myeloid Neoplasia
- Chapter 20 Germline Predisposition to Lymphoid Neoplasm
- Chapter 21 Mastocytosis and Myeloid Lymphoid Neoplasms with Eosinophilia
- Section V Histiocytic Neoplasm and Miscellaneous Bone Marrow Diseases
- Index
- References
Chapter 13 - Precursor Lymphoblastic Leukemia/Lymphoma
from Section IV - Precursor Hematopoietic Neoplasms and Related Neoplasms
Published online by Cambridge University Press: 25 November 2023
Book contents
- Atlas of Pediatric Hematopathology
- Atlas of Pediatric Hematopathology
- Copyright page
- Contents
- Contributors
- Section I Peripheral Blood
- Section II Normal and Non-neoplastic Hematolymphoid Diseases
- Section III Mature Lymphoid Neoplasm
- Section IV Precursor Hematopoietic Neoplasms and Related Neoplasms
- Chapter 13 Precursor Lymphoblastic Leukemia/Lymphoma
- Chapter 14 Blastic Plasmacytoid Dendritic Cell Neoplasm
- Chapter 15 Acute Myeloid Leukemia and Related Precursor Neoplasms
- Chapter 16 Myeloproliferative Neoplasms
- Chapter 17 Myelodysplastic/Myeloproliferative Neoplasms
- Chapter 18 Childhood Myelodysplastic Syndrome
- Chapter 19 Germline Predisposition to Myeloid Neoplasia
- Chapter 20 Germline Predisposition to Lymphoid Neoplasm
- Chapter 21 Mastocytosis and Myeloid Lymphoid Neoplasms with Eosinophilia
- Section V Histiocytic Neoplasm and Miscellaneous Bone Marrow Diseases
- Index
- References
Summary
Precursor lymphoid neoplasms comprise lymphoblastic leukemias (ALLs) and lymphoblastic lymphomas (LBLs), of either B- or T-cell origin. As a general rule, ALLs and LBLs are considered biologically equivalent. The distinction between ALLs and LBLs is arbitrary. Bone marrow or peripheral blood blasts ≥ 25% are defined as ALL. Neoplasms with predominant extramedullary involvement, bone marrow, or peripheral blood blasts < 25% are classified as LBL.
- Type
- Chapter
- Information
- Atlas of Pediatric Hematopathology , pp. 127 - 139Publisher: Cambridge University PressPrint publication year: 2023
References
Borowitz, MJ, Chan, JKC, Downing, JR, Le Beau, MM, Arber, DA. B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC Press; 2017:203–9.Google Scholar
Geethakumari, PR, Hoffmann, MS, Pemmaraju, N, Hu, S, Jorgensen, JL, O’Brien, S, Daver, N. Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/LBL): A diagnostic challenge. Clin Lymphoma, Myeloma Leukemia. 2014 Aug; 14(4): e115.CrossRefGoogle Scholar
Cortelazzo, S, Ponzoni, M, Ferreri, AJ, Hoelzer, D. Lymphoblastic lymphoma. Crit Rev Oncol/Hematol. 2011 Sep 1; 79(3): 330–43.CrossRefGoogle ScholarPubMed
Lin, P, Jones, D, Dorfman, DM, Medeiros, LJ. Precursor B-cell lymphoblastic lymphoma: A predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol. 2000 Nov 1; 24(11): 1480–90.CrossRefGoogle ScholarPubMed
Soslow, RA, Baergen, RN, Warnke, RA. B‐lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology. Cancer. 1999 Jun 15; 85(12): 2648–54.3.0.CO;2-R>CrossRefGoogle ScholarPubMed
Maitra, A, McKenna, RW, Weinberg, AG, Schneider, NR, Kroft, SH. Precursor B-cell lymphoblastic lymphoma: A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol. 2001 Jun 1; 115(6): 868–75.CrossRefGoogle ScholarPubMed
Perkins, SL, McKenna, R. Precursor lymphoid neoplasms. In Kjeldsberg, CR, Perkins, SL, eds. Practical diagnosis of hematologic disorders, 5th ed., Volume 2, Malignant disorders. Singapore: American Society for Clinical Pathology; 2010:691–719.Google Scholar
Duffied, AS, Racke, FK, Borowitz, MJ. Precursor B- and T-cell neoplasms. In Jaffe, E, Arber, D, Campo, E, Harris, NL, Quintanilla-Martinez, L, eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:761–73.Google Scholar
Inaba, H, Mullighan, CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020 Nov 1; 105(11): 2524–39.CrossRefGoogle ScholarPubMed
Hunger, SP, Mullighan, CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015 Oct 15; 373(16): 1541–52.CrossRefGoogle ScholarPubMed
Van der Linden, MH, Valsecchi, MG, De Lorenzo, P, Möricke, A, Janka, G, Leblanc, TM, et al. Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Blood. 2009 Oct 29; 114(18): 3764–8.CrossRefGoogle ScholarPubMed
Pieters, R, Schrappe, M, De Lorenzo, P, Hann, I, De Rossi, G, Felice, M, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial. Lancet. 2007 Jul 21; 370(9583): 240–50.CrossRefGoogle Scholar
Van der Linden, MH, Creemers, S, Pieters, R. Diagnosis and management of neonatal leukaemia. Semin Fetal Neonatal Med. 2012 Aug 1; 17(4): 192–5.CrossRefGoogle ScholarPubMed
Knez, V, Liu, X, Schowinsky, J, Pan, Z, Wang, D, Lorsbach, R, et al. Clinicopathologic and genetic spectrum of infantile B-lymphoblastic leukemia: A multi-institutional study. Leukemia Lymphoma. 2019 Mar 21; 60(4): 1006–13.CrossRefGoogle ScholarPubMed
Kang, H, Wilson, CS, Harvey, RC, Chen, I, Murphy, MH, Atlas, SR, et al. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children’s Oncology Group study. Blood. 2012 Feb 23; 119(8): 1872–81.CrossRefGoogle ScholarPubMed
Sakaki, H, Kanegane, H, Nomura, K, Goi, K, Sugita, K, Miura, M, et al. Early lineage switch in an infant acute lymphoblastic leukemia. Int J Hematol. 2009 Dec; 90(5): 653–5.CrossRefGoogle Scholar
Rossi, JG, Bernasconi, AR, Alonso, CN, Rubio, PL, Gallego, MS, Carrara, CA, et al. Lineage switch in childhood acute leukemia: An unusual event with poor outcome. Am J Hematol. 2012 Sep; 87(9): 890–7.CrossRefGoogle ScholarPubMed
Park, M, Koh, KN, Kim, BE, Im, HJ, Jang, S, Park, CJ, et al. Lineage switch at relapse of childhood acute leukemia: A report of four cases. J Korean Med Sci. 2011 Jun; 26(6): 829–31.CrossRefGoogle ScholarPubMed
Borowitz, MJ, Chan, JKC, Béné, M-C, Arber, A. T-lymphoblastic leukaemia/lymphoma. In Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC Press; 2017:209–12.Google Scholar
Raetz, EA, Perkins, SL, Bhojwani, D, Smock, K, Philip, M, Carroll, WL, Min, DJ. Gene expression profiling reveals intrinsic differences between T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma. Pediatr Blood Cancer. 2006 Aug; 47(2): 130–40.CrossRefGoogle ScholarPubMed
Uyttebroeck, A, Vanhentenrijk, V, Hagemeijer, A, Boeckx, N, Renard, M, Wlodarska, I, et al. Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma? Leukemia Lymphoma. 2007; 48(9): 1745–54.CrossRefGoogle Scholar
Coustan-Smith, E, Mullighan, CG, Onciu, M, Behm, FG, Raimondi, SC, Pei, D, et al. Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009 Feb 1; 10(2): 147–56.CrossRefGoogle ScholarPubMed